Intravenous infusion (IV) or intracavitary perfusion (IP) of T3011, an oncolytic HSV expressing IL-12 and PD-1 antibody: Analyses of two phase 1 studies.

被引：0

作者：

Niu, Jiaxin

Barve, Minal A.

Spira, Alexander I.

Edenfield, William Jeffery

Wang, Kevin

Liu, Gaiyun

McKean, Meredith

Fu, Wenmin

Qiu, Meng

Cheng, Peng

机构：

[1] Mary Crowley Canc Res Ctr, Dallas, TX USA

[2] NEXT Oncol Virginia, Fairfax, VA USA

[3] Prisma Hlth Canc Inst, ITOR, Greenville, SC USA

[4] Immvira Co Ltd, Shanghai, Peoples R China

[5] Sarah Cannon Res Inst, Nashville, TN USA

[6] ImmVira Co Ltd, Shenzhen, Peoples R China

[7] Sichuan Univ, West China Hosp, Chengdu, Peoples R China

[8] Nanyang Med Coll, Affiliated Hosp 1, Nanyang, Peoples R China

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e14581

引用

页数：1